Demand for Spinal Surgery Products Is Set To Reach US$ 15.5 Billion in Valuation by 2030 | Fact.MR Research

Spinal Surgery Products Market Analysis By Device (Fusion Devices, Non-fusion Devices & Others) By Disease Indication (Degenerative Disc Disease, Complex Deformity, Traumas/Fractures & Others) By End-Use and By Region

The global demand for spinal surgery products industry enjoys a valuation of over US$ 11 billion in 2022 and is set to further expand at a CAGR of 4.3% to reach US$ 15.5 billion by the year 2030.

Demand for spinal implants and surgical devices has increased with the cost of products coming down all the time. As a result, the industry for spinal surgery equipment is expanding steadily across the world.

Download Free Sample Copy of This Report:

https://www.factmr.com/connectus/sample?flag=S&rep_id=7559

Rising in Global Demand for Spinal Surgery Products

The global demand for spinal surgery products is rising due to a number of factors. The aging population, increasing prevalence of spinal disorders, and technological advancements are all contributing to the increased demand. As the population ages, more people are suffering from spinal disorders such as degenerative disc disease, herniated discs, and spinal stenosis. These conditions can cause severe pain and disability, and require surgical intervention.

Technological advancements have also made spinal surgery safer and more effective, leading to an increased demand for these products. In addition, the rising cost of healthcare is driving up the demand for spinal surgery products. As healthcare costs continue to rise, more people are turning to spinal surgery as a cost–effective solution for their pain and disability. This has led to an increased demand for products such as implants, instruments, and other medical devices used in spinal surgery.

Finally, the growing awareness of the importance of spine health is also driving up the demand for spinal surgery products. As more people become aware of the importance of maintaining a healthy spine, they are more likely to seek out treatments such as spinal surgery. This has led to an increased demand for products used in these procedures.

Share Your Requirements & Get Customized Reports:

https://www.factmr.com/connectus/sample?flag=RC&rep_id=7559

Competitive Landscape

The spinal surgery products industry has a few significant competitors and is moderately competitive. In addition, mid-size to smaller enterprises are enhancing their market position by offering new technologies with greater usability as a result of the increased technology breakthroughs and product innovations.

• The Defender Anterior Cervical Plate & the Stronghold C 3D Titanium Interbody Device, both of which use TiCell 3D advanced surface technology, were introduced by Spine Wave in December 2021.
• The most recent additions to Medtronic PLC’s ecosystem for minimally invasive spine surgery include the Catalyft PL and PL40, Space-D Access System, and Accelerate Graft Delivery System with Grafton DBF.

Key Companies Profiled:

• Zimmer Biomet
• Stryker Corporation
• Depuy Synthes
• Medtronic
• Globus Medical Inc.
• RTI Surgical Holdings
• Ulrich GmbH & Co. KG
• B. Braun Melsungen AG

Full Access to this Report Is Available:

https://www.factmr.com/checkout/7559

Key Segments :

• by Device :
  • Fusion Devices
  • Non-fusion Devices
  • Others
• by Disease Indication :
  • Degenerative Disc Disease
  • Complex Deformity
  • Traumas & Fractures
  • Others
• by End Use :
  • Hospitals
  • Ambulatory Surgery Centers
  • Specialty Clinics
  • Others
• by Region :
  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia & Oceania
  • MEA

Questionnaire answered in the report include:

• How the industry has grown?
• What is the present and future outlook on the basis of region?
• What are the challenges and opportunities?
• Why the consumption in region?
• In which year segment is expected to overtake segment?

For More Insights of Fact.MR Trending Report:-

Bleeding Disorders Treatment Analysis by Type (Hemophilia A, Hemophilia B), by Drug Class (Plasma-derived Coagulation Factor Concentrates, Recombinant Coagulation Factor Concentrates, Fibrin Sealants), by Region – Global Forecast 2027